HOME >> MEDICINE >> NEWS
Warfarin Continues To Be Underused As Stroke Preventive

Despite powerful evidence that the blood-thinning drug warfarin can prevent strokes in people with atrial fibrillation -- a type of irregular heartbeat -- the drug continues to be seriously underprescribed, according to a study by two physicians from the Massachusetts General Hospital (MGH). The report by Randall Stafford, MD, and Daniel Singer, MD, appears in the April 7 issue of Circulation.

Atrial fibrillation is an abnormal rhythm in the contraction of the upper chambers of the heart and is the strongest common risk factor for stroke. By leading to the formation of blood clots that may travel to the brain, the condition accounts for about 80,000 strokes annually. Achieving more widespread use of warfarin, the researchers estimate, could prevent at least 10,000 strokes a year.

The researchers examined how frequently patients with atrial fibrillation received prescriptions for warfarin, based on data from the National Ambulatory Medical Care Survey from 1989 to 1996. Although warfarin use increased from 13 percent of patient visits in 1989 to 40 percent of 1993 visits -- a level the authors believe is still too low -- there was no significant change in usage from 1993 to 1996. They also found that use of aspirin, which also thins the blood but not as effectively as warfarin, increased from 6 percent to 20 percent of patients.

"While not every patient with atrial fibrillation should receive warfarin," says Stafford, "we believe there are many other reasons why doctors may not be prescribing this important drug. The use of blood thinners requires frequent blood tests to reduce the small possibility of abnormal bleeding, and both patients and physicians might be overly concerned about the risks involved with this very important therapy."

The researchers note that the fact that warfarin usage has leveled off at a less-than-optimal level suggests that new strategies, such as specialized anticoagulation clinics, may be needed. In 1996, Staff
'"/>

Contact: Susan McGreevey
smcgreevey@partners.org
617-724-2764
Massachusetts General Hospital
8-Apr-1998


Page: 1 2

Related medicine news :

1. Warfarin effective for stroke prevention in patients with atrial fibrillation
2. Preventing Stroke: The Choice Between Aspirin And Warfarin
3. Beta-Blockers Underused In Older Patients After Heart Attacks, Major Study Of 45,000 Patients 65 Years Or Older Reveals
4. Stroke awareness low among women, especially minorities
5. Stroke warning signs often occur hours or days before attack
6. Canadian neurologist wins highest award as American Stroke Association honors five
7. Stroke patients receive better care when hospitals get with the guidelines
8. Strokes: Dental x-rays reveal more than cavities
9. Stroke treatment window stays open longer than thought, say Stanford researchers
10. Stroke news tips for Saturday, Feb. 7, 2004
11. Stroke news tips for Friday, Feb. 6, 2004

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Warfarin Continues Underused Stroke Preventive

(Date:5/18/2013)... 18, 2013 The Communities of Distinction ... places we call home. These are the townships, villages and ... the locations where the people are friendly and neighbors are ... off the highways and shares the best in both the ... with an American sports and film celebrity. It airs in ...
(Date:5/18/2013)... 18, 2013 The “World Healthcare IT ... studies the major market drivers, restraints, and opportunities in ... , Browse , 89 market ... TOC on "Healthcare IT Market" , ... on reports. , The global healthcare IT market is ...
(Date:5/18/2013)... 2013 TheBeautyPlace.com answers important questions about ... is not a result of stress, nutrient deficiency or ... Magazine, 70% of men suffer from male patterned baldness. ... renowned for hair transplant surgery, but additionally carries a ... known as Bosley Professional Strength. Their product line is ...
(Date:5/18/2013)... May 18, 2013 As metal-on-metal ... throughout the country, Bernstein Liebhard LLP notes that a ... often suffer tissue damage before they experience any pain ... to Science Daily will appear in the Journal of ... underwent MRI screens of their hips. The researchers ...
(Date:5/18/2013)... Although obesity is associated with an increased risk ... esophageal adenocarcinoma, a type of esophageal cancer, is stronger ... on Cancer.gov, last reviewed in January 2012, overweight ... those of normal and healthy weight to develop this ... cancer is not well understood, it is now thought ...
Breaking Medicine News(10 mins):Health News:Communities of Distinction TV Presents "A Place to Call Home" Segment 2Health News:Healthcare IT Market to reach US$ 162.2 Billion by 2015 at a CAGR of 10.2% - New Report by MarketandMarkets 2Health News:Healthcare IT Market to reach US$ 162.2 Billion by 2015 at a CAGR of 10.2% - New Report by MarketandMarkets 3Health News:TheBeautyPlace.com Features the Two New Best-Selling Hairloss Products: Bosley Professional Strength and Nioxin Systems 2Health News:TheBeautyPlace.com Features the Two New Best-Selling Hairloss Products: Bosley Professional Strength and Nioxin Systems 3Health News:Metal-on-Metal Hip Implants: Bernstein Liebhard LLP Comments on New Study Finding that Tissue Damage Precedes Pain in Metal-on-Metal Hip Replacement Patients 2Health News:Metal-on-Metal Hip Implants: Bernstein Liebhard LLP Comments on New Study Finding that Tissue Damage Precedes Pain in Metal-on-Metal Hip Replacement Patients 3Health News:Metal-on-Metal Hip Implants: Bernstein Liebhard LLP Comments on New Study Finding that Tissue Damage Precedes Pain in Metal-on-Metal Hip Replacement Patients 4Health News:hCGtreatments / Diet Doc Hcg Diets & Weight Loss Plans Announces New Prescription Hcg Diet Plans Designed to Trim Inches and Thus Reduce the Risk of Esophageal Cancer 2Health News:hCGtreatments / Diet Doc Hcg Diets & Weight Loss Plans Announces New Prescription Hcg Diet Plans Designed to Trim Inches and Thus Reduce the Risk of Esophageal Cancer 3
(Date:5/17/2013)... May 17, 2013  Orexigen® Therapeutics, Inc. (Nasdaq: ... overview at the UBS Global Healthcare Conference in ... May 22 nd at 11 a.m. Eastern Time. To ... presentation, please visit the Investor Relations section of the Company,s ... available for 14 days after the event. About ...
(Date:5/17/2013)... 17, 2013  Sony Biotechnology Inc. ("Sony") today announced the ... and 130um sorting chip.  Sony will also be exhibiting its ... SH800 Cell Sorter, the EC800 flow cytometer, and new SP6800 ... 2013, which will be held at the San ... California , from May 20 - 22.  ...
(Date:5/17/2013)... , May 17, 2013 ... health economics and outcomes research also   to   ... NASDAQ: SHPG ), the global specialty biopharmaceutical ... 7 poster presentations at the American Psychiatric Association (APA) ... , May 18-22. The data being presented represent Shire,s ...
Breaking Medicine Technology:Sony Delivers New Technology for Science to CYTO 2013 2Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 2Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 3Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 4Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 5Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 6Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 7Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 8Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 9Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 10
Cached News: